[Summary] Focused on developing high-throughput sequencing experimental technolo
Beijing Novogene Co., Ltd. (stock code: 688315) was registered and established in March 2011 in Zhongguancun Life Science Park, Beijing. It is dedicated to pioneering the application of advanced molecular biology technologies and high-performance computing in life science research and human health, and is committed to becoming a leading provider of genetic technology products and services. Headquartered in Beijing, the company has laboratories or experimental bases in Beijing, Tianjin, Guangzhou, Shanghai, the United States, the United Kingdom, Germany, Singapore, and Japan, and has subsidiaries in Hong Kong, China, the United States, the United Kingdom, Singapore, the Netherlands, and Japan, with an office area exceeding 40,000 square meters. Currently, Novogene has established a high-quality, multidisciplinary team composed of talents from prestigious universities at home and abroad, with approximately 52% holding master's degrees or above. The company has built high-throughput, large-scale gene sequencing platforms and high-performance computing platforms, effectively supporting the big data analysis and storage needs of both life science research and medical health. Its business covers about 90 countries and regions across six continents, serving over 7,300 customers. Novogene has established extensive collaborations with numerous academic institutions worldwide and has completed many genomics research projects at internationally advanced levels. As of June 2024, the total number of SCI articles co-authored or cited exceeded 26,520, with a cumulative impact factor of nearly 176,950. The company has obtained 425 software copyrights and 76 patents. Its partners span the globe, including over 4,200 research institutes and universities, over 680 hospitals, and over 2,400 pharmaceutical and agricultural enterprises. As a leading enterprise in the domestic gene sequencing field, Novogene's business covers basic life science research services, medical research and technology services, and library construction and sequencing platform services, providing gene sequencing, mass spectrometry analysis, and bioinformatics technical support to research universities, research institutes, hospitals, pharmaceutical R&D enterprises, and agricultural enterprises worldwide.
What does Beijing Novogene Co., Ltd. require? Who is Novogene hiring? Novogene recruitment: 其他（研发和技术类）占比最多占28.3%，其次是质量管理类占26.4%. What education can get in at Novogene? 硕士占比最多占47.3%，其次是本科占29.9%. High education required at Novogene? 硕士占47.3%，博士占12.3%. Work experience required at Novogene? 不限占比最多占33.9%，其次是3-5年占23.7%. Where are the job locations at Novogene? 天津占比最多占37.6%，其次是北京占35.3%. Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
